Integra LifeSciences Holdings Corporation (IART)
USD 19.49
(-2.84%)
USD 19.49
(-2.84%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.4 Billion USD | 21.28% |
| 2022 | 1.15 Billion USD | 1.83% |
| 2021 | 1.13 Billion USD | -4.0% |
| 2020 | 1.18 Billion USD | -5.85% |
| 2019 | 1.25 Billion USD | 3.58% |
| 2018 | 1.21 Billion USD | -27.06% |
| 2017 | 1.66 Billion USD | 195.98% |
| 2016 | 562.94 Million USD | -15.58% |
| 2015 | 666.83 Million USD | 19.5% |
| 2014 | 558 Million USD | 105.57% |
| 2013 | 271.44 Million USD | -35.77% |
| 2012 | 422.6 Million USD | -2.05% |
| 2011 | 431.45 Million USD | 57.17% |
| 2010 | 274.51 Million USD | -12.47% |
| 2009 | 313.62 Million USD | -22.84% |
| 2008 | 406.45 Million USD | 3.52% |
| 2007 | 392.62 Million USD | 98.94% |
| 2006 | 197.35 Million USD | 176.06% |
| 2005 | 71.48 Million USD | 45.76% |
| 2004 | 49.04 Million USD | 21.77% |
| 2003 | 40.27 Million USD | 192.42% |
| 2002 | -43.58 Million USD | -6.45% |
| 2001 | -40.94 Million USD | -8878.51% |
| 2000 | -456 Thousand USD | 95.15% |
| 1999 | -9.4 Million USD | -77.36% |
| 1998 | -5.3 Million USD | -152.38% |
| 1997 | -2.1 Million USD | 82.2% |
| 1996 | -11.8 Million USD | -162.22% |
| 1995 | -4.5 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -405.52 Million USD | -128.86% |
| 2024 Q2 | 1.79 Billion USD | 542.45% |
| 2024 Q3 | 1.12 Billion USD | -1.11% |
| 2023 Q2 | 1.29 Billion USD | 104.27% |
| 2023 Q4 | 1.4 Billion USD | 82.85% |
| 2023 Q1 | 633.47 Million USD | -45.33% |
| 2023 FY | 1.4 Billion USD | 21.28% |
| 2023 Q3 | 768.52 Million USD | -40.61% |
| 2022 FY | 1.15 Billion USD | 1.83% |
| 2022 Q2 | 1.26 Billion USD | 2.12% |
| 2022 Q1 | 1.24 Billion USD | 9.15% |
| 2022 Q3 | 1.2 Billion USD | -5.19% |
| 2022 Q4 | 1.15 Billion USD | -3.64% |
| 2021 Q3 | 1.18 Billion USD | -5.83% |
| 2021 Q2 | 1.25 Billion USD | -6.4% |
| 2021 FY | 1.13 Billion USD | -4.0% |
| 2021 Q1 | 1.34 Billion USD | 13.17% |
| 2021 Q4 | 1.13 Billion USD | -3.76% |
| 2020 Q2 | 1.3 Billion USD | -2.18% |
| 2020 Q3 | 1.13 Billion USD | -13.1% |
| 2020 Q4 | 1.18 Billion USD | 4.66% |
| 2020 FY | 1.18 Billion USD | -5.85% |
| 2020 Q1 | 1.33 Billion USD | 5.83% |
| 2019 Q1 | 1.2 Billion USD | -0.63% |
| 2019 Q4 | 1.25 Billion USD | -5.33% |
| 2019 FY | 1.25 Billion USD | 3.58% |
| 2019 Q3 | 1.32 Billion USD | 3.6% |
| 2019 Q2 | 1.28 Billion USD | 6.27% |
| 2018 Q3 | 1.22 Billion USD | -5.14% |
| 2018 FY | 1.21 Billion USD | -27.06% |
| 2018 Q4 | 1.21 Billion USD | -0.89% |
| 2018 Q2 | 1.29 Billion USD | -21.3% |
| 2018 Q1 | 1.64 Billion USD | -1.41% |
| 2017 Q1 | 730.88 Million USD | 29.83% |
| 2017 FY | 1.66 Billion USD | 195.98% |
| 2017 Q4 | 1.66 Billion USD | 141.68% |
| 2017 Q3 | 689.44 Million USD | -4.96% |
| 2017 Q2 | 725.4 Million USD | -0.75% |
| 2016 Q1 | 652.91 Million USD | -2.09% |
| 2016 Q2 | 618.73 Million USD | -5.23% |
| 2016 FY | 562.94 Million USD | -15.58% |
| 2016 Q3 | 580.15 Million USD | -6.24% |
| 2016 Q4 | 562.94 Million USD | -2.97% |
| 2015 Q1 | 537.18 Million USD | -3.73% |
| 2015 FY | 666.83 Million USD | 19.5% |
| 2015 Q3 | 650.41 Million USD | 24.4% |
| 2015 Q2 | 522.84 Million USD | -2.67% |
| 2015 Q4 | 666.83 Million USD | 2.52% |
| 2014 Q2 | 493.81 Million USD | -1.23% |
| 2014 Q3 | 482.73 Million USD | -2.24% |
| 2014 Q4 | 558 Million USD | 15.59% |
| 2014 Q1 | 499.96 Million USD | 84.19% |
| 2014 FY | 558 Million USD | 105.57% |
| 2013 Q2 | 444.61 Million USD | 2.99% |
| 2013 FY | 271.44 Million USD | -35.77% |
| 2013 Q4 | 271.44 Million USD | -36.32% |
| 2013 Q3 | 426.27 Million USD | -4.13% |
| 2013 Q1 | 431.69 Million USD | 2.15% |
| 2012 Q2 | 440.47 Million USD | -5.14% |
| 2012 Q3 | 392.01 Million USD | -11.0% |
| 2012 Q4 | 422.6 Million USD | 7.8% |
| 2012 FY | 422.6 Million USD | -2.05% |
| 2012 Q1 | 464.33 Million USD | 7.62% |
| 2011 Q1 | 101.89 Million USD | -62.88% |
| 2011 Q2 | 7.09 Million USD | -93.04% |
| 2011 Q3 | 430.61 Million USD | 5968.39% |
| 2011 FY | 431.45 Million USD | 57.17% |
| 2011 Q4 | 431.45 Million USD | 0.2% |
| 2010 Q4 | 274.51 Million USD | -5.56% |
| 2010 FY | 274.51 Million USD | -12.47% |
| 2010 Q3 | 290.68 Million USD | 4.46% |
| 2010 Q2 | 278.28 Million USD | -4.41% |
| 2010 Q1 | 291.1 Million USD | -7.18% |
| 2009 Q3 | 294.7 Million USD | -7.16% |
| 2009 Q2 | 317.43 Million USD | -8.17% |
| 2009 FY | 313.62 Million USD | -22.84% |
| 2009 Q4 | 313.62 Million USD | 6.42% |
| 2009 Q1 | 345.67 Million USD | -14.95% |
| 2008 Q3 | 420.66 Million USD | 12.88% |
| 2008 Q1 | 370.36 Million USD | -5.67% |
| 2008 FY | 406.45 Million USD | 3.52% |
| 2008 Q2 | 372.66 Million USD | 0.62% |
| 2008 Q4 | 406.45 Million USD | -3.38% |
| 2007 Q2 | 329.12 Million USD | 72.61% |
| 2007 FY | 392.62 Million USD | 98.94% |
| 2007 Q4 | 392.62 Million USD | 22.52% |
| 2007 Q3 | 320.46 Million USD | -2.63% |
| 2007 Q1 | 190.67 Million USD | -3.39% |
| 2006 FY | 197.35 Million USD | 176.06% |
| 2006 Q3 | 182.77 Million USD | 18.24% |
| 2006 Q2 | 154.57 Million USD | 38.29% |
| 2006 Q1 | 111.77 Million USD | 56.35% |
| 2006 Q4 | 197.35 Million USD | 7.98% |
| 2005 Q1 | 85.86 Million USD | 75.08% |
| 2005 FY | 71.48 Million USD | 45.76% |
| 2005 Q4 | 71.48 Million USD | -11.87% |
| 2005 Q3 | 81.11 Million USD | -10.01% |
| 2005 Q2 | 90.13 Million USD | 4.97% |
| 2004 Q1 | 43.69 Million USD | 8.47% |
| 2004 FY | 49.04 Million USD | 21.77% |
| 2004 Q4 | 49.04 Million USD | -41.83% |
| 2004 Q3 | 84.3 Million USD | 11.23% |
| 2004 Q2 | 75.79 Million USD | 73.49% |
| 2003 Q2 | 3.5 Million USD | 957.84% |
| 2003 FY | 40.27 Million USD | 192.42% |
| 2003 Q4 | 40.27 Million USD | 12.01% |
| 2003 Q3 | 35.96 Million USD | 927.43% |
| 2003 Q1 | -408 Thousand USD | 99.06% |
| 2002 Q2 | -51.19 Million USD | -9.48% |
| 2002 Q3 | -50.14 Million USD | 2.06% |
| 2002 Q4 | -43.58 Million USD | 13.08% |
| 2002 FY | -43.58 Million USD | -6.45% |
| 2002 Q1 | -46.76 Million USD | -14.22% |
| 2001 FY | -40.94 Million USD | -8878.51% |
| 2001 Q1 | -3.12 Million USD | -584.43% |
| 2001 Q2 | 1.1 Million USD | 135.28% |
| 2001 Q4 | -40.94 Million USD | 31.0% |
| 2001 Q3 | -59.33 Million USD | -5489.01% |
| 2000 Q3 | 614 Thousand USD | -91.14% |
| 2000 Q1 | -11.11 Million USD | -18.2% |
| 2000 FY | -456 Thousand USD | 95.15% |
| 2000 Q4 | -456 Thousand USD | -174.27% |
| 2000 Q2 | 6.93 Million USD | 162.38% |
| 1999 Q1 | 3.4 Million USD | 164.15% |
| 1999 Q2 | -1.3 Million USD | -138.24% |
| 1999 FY | -9.4 Million USD | -77.36% |
| 1999 Q3 | -2.6 Million USD | -100.0% |
| 1999 Q4 | -9.4 Million USD | -261.54% |
| 1998 Q4 | -5.3 Million USD | -103.85% |
| 1998 Q1 | -5.9 Million USD | -180.95% |
| 1998 Q2 | -4.7 Million USD | 20.34% |
| 1998 Q3 | -2.6 Million USD | 44.68% |
| 1998 FY | -5.3 Million USD | -152.38% |
| 1997 Q3 | -8.2 Million USD | -90.7% |
| 1997 FY | -2.1 Million USD | 82.2% |
| 1997 Q1 | -8.8 Million USD | 25.42% |
| 1997 Q2 | -4.3 Million USD | 51.14% |
| 1997 Q4 | -2.1 Million USD | 74.39% |
| 1996 FY | -11.8 Million USD | -162.22% |
| 1996 Q3 | -8 Million USD | 17.53% |
| 1996 Q2 | -9.7 Million USD | 19.17% |
| 1996 Q1 | -12 Million USD | -166.67% |
| 1996 Q4 | -11.8 Million USD | -47.5% |
| 1995 FY | -4.5 Million USD | 0.0% |
| 1995 Q3 | -7.2 Million USD | 0.0% |
| 1995 Q4 | -4.5 Million USD | 37.5% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | -5088.982% |
| BrainsWay Ltd. | -10.32 Million USD | 13717.054% |
| Cerus Corporation | 84.35 Million USD | -1565.971% |
| Envoy Medical, Inc. | -3.81 Million USD | 36945.307% |
| electroCore, Inc. | -9.95 Million USD | 14216.323% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 27520.098% |
| IceCure Medical Ltd | -9.93 Million USD | 14246.165% |
| Inogen, Inc. | -103.56 Million USD | 1456.854% |
| OrthoPediatrics Corp. | -9.26 Million USD | 15264.347% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 38695.99% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 10829.754% |
| MaxCyte, Inc. | -27.76 Million USD | 5161.701% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 27450.225% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 244170.952% |
| Orthofix Medical Inc. | 96.44 Million USD | -1357.124% |
| PAVmed Inc | 29.08 Million USD | -4731.465% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 8396.121% |
| RxSight, Inc. | -6.68 Million USD | 21137.126% |
| Sight Sciences, Inc. | -102.71 Million USD | 1468.135% |
| SI-BONE, Inc. | 5.72 Million USD | -24463.538% |
| TELA Bio, Inc. | -3.94 Million USD | 35685.718% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | -2351.597% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -399127.273% |
| Acutus Medical, Inc. | 12.27 Million USD | -11344.58% |
| Talis Biomedical Corporation | -57.06 Million USD | 2562.638% |
| Spectral AI, Inc. | -3.5 Million USD | 40239.389% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 3026.021% |
| CVRx, Inc. | -59.95 Million USD | 2443.852% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -70725.469% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -109890.553% |
| Bioventus Inc. | 372.51 Million USD | -277.244% |
| Venus Concept Inc. | 74.3 Million USD | -1791.334% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 13901.611% |
| LivaNova PLC | 62.53 Million USD | -2147.297% |
| 908 Devices Inc. | -115.09 Million USD | 1320.963% |
| Alphatec Holdings, Inc. | 320.7 Million USD | -338.179% |
| Nemaura Medical Inc. | 9.92 Million USD | -14058.97% |
| NeuroPace, Inc. | 54.33 Million USD | -2486.23% |
| LENSAR, Inc. | -18.31 Million USD | 7774.093% |
| Apyx Medical Corporation | -5.15 Million USD | 27381.693% |
| Cutera, Inc. | 288.3 Million USD | -387.437% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | -18599.667% |
| BioSig Technologies, Inc. | 262 Thousand USD | -536266.412% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 3306.206% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 15376.443% |
| Axonics, Inc. | -77.19 Million USD | 1920.452% |
| Outset Medical, Inc. | 67.67 Million USD | -1976.39% |
| IRIDEX Corporation | -4.28 Million USD | 32872.388% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 889.403% |
| IRadimed Corporation | -47.71 Million USD | 3044.897% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 46540.185% |
| INVO Bioscience, Inc. | 8.45 Million USD | -16528.295% |
| Telesis Bio, Inc. | 32.63 Million USD | -4206.052% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 56263.304% |
| Varex Imaging Corporation | 316.9 Million USD | -343.446% |
| Quipt Home Medical Corp. | 81.73 Million USD | -1619.323% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 50613.3% |
| Pulmonx Corporation | -42.36 Million USD | 3417.469% |
| Dynatronics Corporation | 6.2 Million USD | -22551.072% |
| Modular Medical, Inc. | -8.04 Million USD | 17574.26% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 32803.747% |
| Semler Scientific, Inc. | -57.13 Million USD | 2559.793% |
| InMode Ltd. | -135.39 Million USD | 1137.919% |
| Bruker Corporation | 891.3 Million USD | -57.666% |
| Cytosorbents Corporation | 4.18 Million USD | -33502.94% |
| DexCom, Inc. | 2.02 Billion USD | 30.696% |
| Align Technology, Inc. | -840.47 Million USD | 267.202% |
| Viveve Medical, Inc. | -13.81 Million USD | 10273.605% |
| ZimVie Inc. | 450.41 Million USD | -211.994% |
| Movano Inc. | -5.86 Million USD | 24056.359% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 1145.16% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 244170.952% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -70725.469% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | -293.858% |
| Profound Medical Corp. | -18.17 Million USD | 7830.444% |
| Insulet Corporation | 798.1 Million USD | -76.078% |
| enVVeno Medical Corporation | -2.21 Million USD | 63457.98% |
| Surmodics, Inc. | -12.01 Million USD | 11797.02% |
| iCAD, Inc. | -21.2 Million USD | 6725.866% |
| Nuwellis, Inc. | -2.81 Million USD | 49950.302% |
| Biotricity, Inc. | 23.09 Million USD | -5985.378% |
| iRhythm Technologies, Inc. | 93.65 Million USD | -1400.55% |
| Aethlon Medical, Inc. | -4.5 Million USD | 31316.915% |
| InspireMD, Inc. | -8.04 Million USD | 17567.744% |
| PAVmed Inc. | 29.08 Million USD | -4731.465% |
| BIOLASE, Inc. | 11.34 Million USD | -12287.87% |
| Beyond Air, Inc. | 6.22 Million USD | -22460.283% |
| FONAR Corporation | -14.66 Million USD | 9682.332% |
| AxoGen, Inc. | 32.26 Million USD | -4255.297% |
| Vivani Medical, Inc. | 42 Thousand USD | -3345804.762% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 13285.213% |
| Inari Medical, Inc. | -7.16 Million USD | 19724.072% |
| UFP Technologies, Inc. | 40.77 Million USD | -3346.51% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -45695.119% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 29552.708% |
| Tenon Medical, Inc. | -1.25 Million USD | 112074.502% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 18575.94% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 11883.023% |
| AdaptHealth Corp. | 2.21 Billion USD | 36.628% |
| Sintx Technologies, Inc. | 905 Thousand USD | -155179.558% |
| NanoVibronix, Inc. | -3.27 Million USD | 42970.043% |
| Quanterix Corporation | -132.95 Million USD | 1156.935% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 50613.3% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 6383.389% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | -86.446% |
| TransMedics Group, Inc. | 121.13 Million USD | -1060.104% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 5467.762% |
| NeuroMetrix, Inc. | -1.49 Million USD | 94346.414% |
| Hyperfine, Inc. | -75.61 Million USD | 1958.369% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | -823.378% |
| Biomerica, Inc. | -3.38 Million USD | 41614.919% |
| Bone Biologics Corporation | -3.02 Million USD | 46531.454% |
| AVITA Medical, Inc. | -26.23 Million USD | 5457.199% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 76539.926% |
| Silk Road Medical, Inc | 64.42 Million USD | -2081.333% |